Akoustis Technologies, INC Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
NASDAQ
Director Glenn Gormley was granted 37,866 stock options in Aktis Oncology, Inc. with an exercise price of $18.09.